159 related articles for article (PubMed ID: 24771612)
1. Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer.
Wang PW; Abedini MR; Yang LX; Ding AA; Figeys D; Chang JY; Tsang BK; Shieh DB
Int J Cancer; 2014 Dec; 135(12):2760-9. PubMed ID: 24771612
[TBL] [Abstract][Full Text] [Related]
2. Cell fate regulation by gelsolin in human gynecologic cancers.
Abedini MR; Wang PW; Huang YF; Cao M; Chou CY; Shieh DB; Tsang BK
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14442-7. PubMed ID: 25246592
[TBL] [Abstract][Full Text] [Related]
3. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
5. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
6. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer.
Yang XH; Feng ZE; Yan M; Hanada S; Zuo H; Yang CZ; Han ZG; Guo W; Chen WT; Zhang P
PLoS One; 2012; 7(3):e31601. PubMed ID: 22403616
[TBL] [Abstract][Full Text] [Related]
7. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
Kim EH; Jang H; Shin D; Baek SH; Roh JL
Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
[TBL] [Abstract][Full Text] [Related]
8. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
Shin D; Kim EH; Lee J; Roh JL
Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
[TBL] [Abstract][Full Text] [Related]
9. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
[TBL] [Abstract][Full Text] [Related]
10. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
11. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?
Li J; Sasaki H; Sheng YL; Schneiderman D; Xiao CW; Kotsuji F; Tsang BK
Biol Signals Recept; 2000; 9(2):122-30. PubMed ID: 10810207
[TBL] [Abstract][Full Text] [Related]
13. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
14. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
15. Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.
Kim EH; Baek S; Shin D; Lee J; Roh JL
Oxid Med Cell Longev; 2017; 2017():5498908. PubMed ID: 29456786
[TBL] [Abstract][Full Text] [Related]
16. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.
Roh JL; Kim EH; Park JY; Kim JW
Mol Cancer Ther; 2015 Aug; 14(8):1907-15. PubMed ID: 26063766
[TBL] [Abstract][Full Text] [Related]
18. XIAP-mediated protection of H460 lung cancer cells against cisplatin.
Cheng YJ; Jiang HS; Hsu SL; Lin LC; Wu CL; Ghanta VK; Hsueh CM
Eur J Pharmacol; 2010 Feb; 627(1-3):75-84. PubMed ID: 19903469
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells.
Tong QS; Zheng LD; Wang L; Zeng FQ; Chen FM; Dong JH; Lu GC
Cancer Gene Ther; 2005 May; 12(5):509-14. PubMed ID: 15706355
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
